Stocks To Buy

Essex Property Trust, Inc. (ESS) has been a steady player in the real estate market, and its latest move further solidifies its position as a reliable high-yield pick for retail investors. The company recently announced that it will maintain its steady dividend, providing investors with a consistent source of income. With a current dividend yield of 3.1%, ESS offers a competitive return for investors seeking stable income streams. This is especially attractive in today's market, where interest rates remain low and ...
Read More About This

Broadcom (AVGO) stock has caught the attention of Seaport Global, with the investment firm predicting big potential for the company thanks to its use of artificial intelligence (AI). In a recent report, Seaport Global highlighted Broadcom's strong track record in incorporating AI into its products, which has allowed the company to stay ahead of the competition in the rapidly advancing tech industry. According to Seaport Global, Broadcom's use of AI in its products has not only increased efficiency and reduced costs, ...
Read More About This

Jim Cramer, the well-known host of CNBC's "Mad Money," recently shared his thoughts on 12 stocks that have been making headlines. As a retail investor, it's important to pay attention to what experts like Cramer are saying about the market. So, let's take a look at the stocks he's been talking about and what it means for your portfolio. First on the list is Apple (AAPL), a company that needs no introduction. Cramer believes that Apple's recent dip in stock price ...
Read More About This

Cryptocurrency exchange platform Coinbase Global (COIN) saw a sharp decline in its stock price yesterday, dropping over 6% in a single day. This sudden crash was largely due to a sell-off in the overall crypto market, as Bitcoin and other major cryptocurrencies also experienced significant drops. So, what does this mean for retail investors? First, it's important to understand that Coinbase's stock is highly correlated with the performance of the crypto market. As the leading platform for buying and selling cryptocurrencies, ...
Read More About This

Fossil Group, Inc. (NASDAQ:FOSL) recently held its Q1 2025 earnings call, and there were some key takeaways for investors to pay attention to. First and foremost, Fossil reported a strong quarter, with a 10% increase in net sales and a 20% increase in e-commerce sales. This is a positive sign for the company, especially in the current retail landscape. One of the most interesting points from the call was Fossil's focus on its direct-to-consumer business. The company saw a 60% increase in ...
Read More About This

While investors are getting bullish again, the big tech trend is AI. Companies are even mentioning AI more often in their earnings reports than tariffs. That’s good news for growth investors. For investors who are already in on the AI space or are looking for another high-growth trend, good news. Other tech spaces continue to look strong, and many of them carry companies with higher growth profiles than AI plays right now. That includes the growth of commercial space technology. In less ...
Read More About This

Investing in artificial intelligence (AI) has been a hot topic in the financial world, and it seems like Meta Platforms CEO Mark Zuckerberg is reaping the rewards. According to prominent tech analyst Gene Munster, Zuckerberg is on "Cloud9" as his company's investments in AI are paying off. Munster, known for his spot-on predictions in the tech industry, believes that Meta Platforms (formerly known as Facebook) is leading the way in AI advancements. He notes that the company's AI technology is not ...
Read More About This

Teva Pharmaceutical Industries Limited (TEVA) has been a hot topic among investors recently, and for good reason. The company's stock has seen a significant increase in value over the past few months, leading many to wonder if this trend will continue. So, what's the bull case for TEVA? First and foremost, TEVA has been making some strategic moves that are paying off. The company has been working to streamline its business, cutting costs and focusing on its core generic drug portfolio ...
Read More About This